Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALEX-XL: Alfuzosin XL in LUTS/BPH
NCT00575913Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Primary endpoint: Improvements in urinary symptoms and quality of life index. Started Sep 2003; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00575913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575913.